MDMA’s potential spotlighted for PTSD treatment
Author of the article: Washington Post – Daniel Gilbert, David Ovalle
Published Jun 05, 2024 • 5 minute read
Article content
A U.S. Food and Drug Administration advisory committee voted against MDMA-assisted therapy for PTSD, raising concerns about the drug’s risks.
The FDA faces a decision on whether to approve MDMA for medical treatment, a significant move in psychedelic therapy.
\
[ad_2]
Source link
